343 related articles for article (PubMed ID: 19339377)
1. Characterization of human hepatic and extrahepatic UDP-glucuronosyltransferase enzymes involved in the metabolism of classic cannabinoids.
Mazur A; Lichti CF; Prather PL; Zielinska AK; Bratton SM; Gallus-Zawada A; Finel M; Miller GP; Radomińska-Pandya A; Moran JH
Drug Metab Dispos; 2009 Jul; 37(7):1496-504. PubMed ID: 19339377
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of UDP-Glucuronosyltransferase Enzymes by Major Cannabinoids and Their Metabolites.
Nasrin S; Watson CJW; Bardhi K; Fort G; Chen G; Lazarus P
Drug Metab Dispos; 2021 Dec; 49(12):1081-1089. PubMed ID: 34493601
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions.
Nasrin S; Watson CJW; Perez-Paramo YX; Lazarus P
Drug Metab Dispos; 2021 Dec; 49(12):1070-1080. PubMed ID: 34493602
[TBL] [Abstract][Full Text] [Related]
4. The properties of UDP-glucuronyltransferase for cannabinoids in rat liver microsomes.
Watanabe K; Kita M; Yamamoto I; Oguri K; Yoshimura H
J Pharmacobiodyn; 1983 Aug; 6(8):581-7. PubMed ID: 6315914
[TBL] [Abstract][Full Text] [Related]
5. Hepatic Enzymes Relevant to the Disposition of (-)-∆
Patilea-Vrana GI; Anoshchenko O; Unadkat JD
Drug Metab Dispos; 2019 Mar; 47(3):249-256. PubMed ID: 30567877
[TBL] [Abstract][Full Text] [Related]
6. Characterization of benzo(a)pyrene-trans-7,8-dihydrodiol glucuronidation by human tissue microsomes and overexpressed UDP-glucuronosyltransferase enzymes.
Fang JL; Beland FA; Doerge DR; Wiener D; Guillemette C; Marques MM; Lazarus P
Cancer Res; 2002 Apr; 62(7):1978-86. PubMed ID: 11929814
[TBL] [Abstract][Full Text] [Related]
7. Glucuronidation of monohydroxylated warfarin metabolites by human liver microsomes and human recombinant UDP-glucuronosyltransferases.
Zielinska A; Lichti CF; Bratton S; Mitchell NC; Gallus-Zawada A; Le VH; Finel M; Miller GP; Radominska-Pandya A; Moran JH
J Pharmacol Exp Ther; 2008 Jan; 324(1):139-48. PubMed ID: 17921187
[TBL] [Abstract][Full Text] [Related]
8. Troglitazone glucuronidation in human liver and intestine microsomes: high catalytic activity of UGT1A8 and UGT1A10.
Watanabe Y; Nakajima M; Yokoi T
Drug Metab Dispos; 2002 Dec; 30(12):1462-9. PubMed ID: 12433820
[TBL] [Abstract][Full Text] [Related]
9. Glucuronidation of DRF-6574, hydroxy metabolite of DRF-4367 (a novel COX-2 inhibitor) by pooled human liver, intestinal microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT1A1, 1A3 and 1A8.
Muzeeb S; Basha SJ; Shashikumar D; Mullangi R; Srinivas NR
Eur J Drug Metab Pharmacokinet; 2006; 31(4):299-309. PubMed ID: 17315542
[TBL] [Abstract][Full Text] [Related]
10. Characterizing and Quantifying Extrahepatic Metabolism of (-)-Δ
Kumar AR; Patilea-Vrana GI; Anoshchenko O; Unadkat JD
Drug Metab Dispos; 2022 Jun; 50(6):734-740. PubMed ID: 35370140
[TBL] [Abstract][Full Text] [Related]
11. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
[TBL] [Abstract][Full Text] [Related]
12. Assessment of UDP-glucuronosyltransferase catalyzed formation of Picroside II glucuronide in microsomes of different species and recombinant UGTs.
Li T; Zheng Y; Fu F; Ji H; Chen X; Zhao Y; Zhao D; Li N; Zhang L
Xenobiotica; 2011 Jul; 41(7):530-7. PubMed ID: 21524190
[TBL] [Abstract][Full Text] [Related]
13. Characterization of hepatic and intestinal glucuronidation of magnolol: application of the relative activity factor approach to decipher the contributions of multiple UDP-glucuronosyltransferase isoforms.
Zhu L; Ge G; Zhang H; Liu H; He G; Liang S; Zhang Y; Fang Z; Dong P; Finel M; Yang L
Drug Metab Dispos; 2012 Mar; 40(3):529-38. PubMed ID: 22180045
[TBL] [Abstract][Full Text] [Related]
14. In Vitro Inhibition of Carboxylesterase 1 by Major Cannabinoids and Selected Metabolites.
Qian Y; Wang X; Markowitz JS
Drug Metab Dispos; 2019 May; 47(5):465-472. PubMed ID: 30833288
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Predictions of Cytochrome P450 (P450)-Mediated In Vivo Cannabinoid-Drug Interactions Based on Reversible and Time-Dependent P450 Inhibition in Human Liver Microsomes.
Bansal S; Paine MF; Unadkat JD
Drug Metab Dispos; 2022 Apr; 50(4):351-360. PubMed ID: 35115300
[TBL] [Abstract][Full Text] [Related]
16. Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine.
Shiraga T; Yajima K; Suzuki K; Suzuki K; Hashimoto T; Iwatsubo T; Miyashita A; Usui T
Drug Metab Dispos; 2012 Feb; 40(2):276-82. PubMed ID: 22031623
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes.
Watanabe K; Yamaori S; Funahashi T; Kimura T; Yamamoto I
Life Sci; 2007 Mar; 80(15):1415-9. PubMed ID: 17303175
[TBL] [Abstract][Full Text] [Related]
18. Glucuronidation of active tamoxifen metabolites by the human UDP glucuronosyltransferases.
Sun D; Sharma AK; Dellinger RW; Blevins-Primeau AS; Balliet RM; Chen G; Boyiri T; Amin S; Lazarus P
Drug Metab Dispos; 2007 Nov; 35(11):2006-14. PubMed ID: 17664247
[TBL] [Abstract][Full Text] [Related]
19. Involvement of multiple UDP-glucuronosyltransferase 1A isoforms in glucuronidation of 5-(4'-hydroxyphenyl)-5-phenylhydantoin in human liver microsomes.
Nakajima M; Sakata N; Ohashi N; Kume T; Yokoi T
Drug Metab Dispos; 2002 Nov; 30(11):1250-6. PubMed ID: 12386132
[TBL] [Abstract][Full Text] [Related]
20. Regioselective glucuronidation of the isoflavone calycosin by human liver microsomes and recombinant human UDP-glucuronosyltransferases.
Ruan JQ; Yan R
Chem Biol Interact; 2014 Sep; 220():231-40. PubMed ID: 25044472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
